These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 15252388

  • 1. [Radical peritonectomy in 37 patients with stage II and III ovarian cancer].
    Capretti PG, Zeppieri MC, Simonetti A, Rosato S, Lovotti D, Battaini A, Capretti G, Agnes Pradelli B.
    Minerva Chir; 2004 Jun; 59(3):233-41. PubMed ID: 15252388
    [Abstract] [Full Text] [Related]

  • 2. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial.
    Trimbos JB, Vergote I, Bolis G, Vermorken JB, Mangioni C, Madronal C, Franchi M, Tateo S, Zanetta G, Scarfone G, Giurgea L, Timmers P, Coens C, Pecorelli S, EORTC-ACTION collaborators. European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm.
    J Natl Cancer Inst; 2003 Jan 15; 95(2):113-25. PubMed ID: 12529344
    [Abstract] [Full Text] [Related]

  • 3. [Experience in first-line chemotherapy with paclitaxel for the treatment of ovarian carcinomas].
    Pete I, Szánthó A, Mayer A, Thurzó L, Pulay T.
    Orv Hetil; 2003 May 11; 144(19):919-24. PubMed ID: 12809068
    [Abstract] [Full Text] [Related]

  • 4. Carcinosarcoma of the ovary-a case series.
    Rutledge TL, Gold MA, McMeekin DS, Huh WK, Powell MA, Lewin SN, Mutch DG, Johnson GA, Walker JL, Mannel RS.
    Gynecol Oncol; 2006 Jan 11; 100(1):128-32. PubMed ID: 16213011
    [Abstract] [Full Text] [Related]

  • 5. Medical treatment of epithelial ovarian cancer.
    González-Martín AJ.
    Expert Rev Anticancer Ther; 2004 Dec 11; 4(6):1125-43. PubMed ID: 15606338
    [Abstract] [Full Text] [Related]

  • 6. Radical surgery-peritonectomy and intraoperative intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis in recurrent or primary ovarian cancer.
    Rufián S, Muñoz-Casares FC, Briceño J, Díaz CJ, Rubio MJ, Ortega R, Ciria R, Morillo M, Aranda E, Muntané J, Pera C.
    J Surg Oncol; 2006 Sep 15; 94(4):316-24. PubMed ID: 16917864
    [Abstract] [Full Text] [Related]

  • 7. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer.
    Gadducci A, Iacconi P, Fanucchi A, Cosio S, Teti G, Genazzani AR.
    Anticancer Res; 2000 Sep 15; 20(3B):1959-64. PubMed ID: 10928134
    [Abstract] [Full Text] [Related]

  • 8. Effect of adjuvant paclitaxel and carboplatin for advanced stage epithelial ovarian cancer: a population-based cohort study of all patients in western Sweden with long-term follow-up.
    Akeson M, Zetterqvist BM, Dahllöf K, Brännström M, Horvath G.
    Acta Obstet Gynecol Scand; 2008 Sep 15; 87(12):1343-52. PubMed ID: 18951208
    [Abstract] [Full Text] [Related]

  • 9. Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy.
    Petit T, Velten M, d'Hombres A, Marchal C, Montbarbon X, Mornex F, Quetin P, Gérard JP, Romestaing P, Carrie C.
    Gynecol Oncol; 2007 Jan 15; 104(1):104-8. PubMed ID: 16987544
    [Abstract] [Full Text] [Related]

  • 10. Second line platinum-based intraperitoneal chemotherapy for advanced ovarian cancer.
    Milczek T, Klasa-Mazurkiewicz D, Emerich J, Kobierski J.
    Acta Obstet Gynecol Scand; 2009 Jan 15; 88(4):463-7. PubMed ID: 19235559
    [Abstract] [Full Text] [Related]

  • 11. Peritonectomy and hyperthermic chemotherapy in patients with advanced or recurrent ephitelial ovarian cancer: a single center cohort study.
    Massari R, Barone M, Basilico R, Carella C, Colasante A, De Tursi M, Filippone A, Guetti L, Mani A.
    Minerva Chir; 2014 Feb 15; 69(1):17-26. PubMed ID: 24675243
    [Abstract] [Full Text] [Related]

  • 12. [Impact of dose delivery of postoperative first-line chemotherapy on prognosis of stage III C epithelial ovarian carcinoma].
    Zhao XD, Zhang Q, Zhang Y.
    Ai Zheng; 2005 Aug 15; 24(8):1002-5. PubMed ID: 16086882
    [Abstract] [Full Text] [Related]

  • 13. Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.
    Pectasides D, Fountzilas G, Aravantinos G, Kalofonos C, Efstathiou H, Farmakis D, Skarlos D, Pavlidis N, Economopoulos T, Dimopoulos MA.
    Gynecol Oncol; 2006 Aug 15; 102(2):285-91. PubMed ID: 16516283
    [Abstract] [Full Text] [Related]

  • 14. Ovarian carcinosarcomas: clinicopathological prognostic factors and evaluation of chemotherapy regimens containing platinum.
    Cicin I, Saip P, Eralp Y, Selam M, Topuz S, Ozluk Y, Aydin Y, Topuz E.
    Gynecol Oncol; 2008 Jan 15; 108(1):136-40. PubMed ID: 17936342
    [Abstract] [Full Text] [Related]

  • 15. Intraperitoneal cisplatin and paclitaxel versus intravenous carboplatin and paclitaxel chemotherapy for Stage III ovarian cancer: a cost-effectiveness analysis.
    Bristow RE, Santillan A, Salani R, Diaz-Montes TP, Giuntoli RL, Meisner BC, Armstrong DK, Frick KD.
    Gynecol Oncol; 2007 Sep 15; 106(3):476-81. PubMed ID: 17688927
    [Abstract] [Full Text] [Related]

  • 16. Cytoreduction combined with intraperitoneal hyperthermic perfusion chemotherapy in advanced/recurrent ovarian cancer patients: The experience of National Cancer Institute of Milan.
    Raspagliesi F, Kusamura S, Campos Torres JC, de Souza GA, Ditto A, Zanaboni F, Younan R, Baratti D, Mariani L, Laterza B, Deraco M.
    Eur J Surg Oncol; 2006 Aug 15; 32(6):671-5. PubMed ID: 16621425
    [Abstract] [Full Text] [Related]

  • 17. Four cycles of paclitaxel and carboplatin as adjuvant treatment in early-stage ovarian cancer: a six-year experience of the Hellenic Cooperative Oncology Group.
    Bamias A, Papadimitriou C, Efstathiou E, Rodolakis A, Vlahos G, Voulgaris Z, Bozas G, Fountzilas G, Aravantinos G, Razis E, Gika D, Dimopoulos MA.
    BMC Cancer; 2006 Sep 25; 6():228. PubMed ID: 16999858
    [Abstract] [Full Text] [Related]

  • 18. Activity of chemotherapy in mucinous epithelial ovarian cancer: a retrospective study.
    Pisano C, Greggi S, Tambaro R, Losito S, Iodice F, Di Maio M, Ferrari E, Falanga M, Formato R, Iaffaioli VR, Pignata S.
    Anticancer Res; 2005 Sep 25; 25(5):3501-5. PubMed ID: 16101169
    [Abstract] [Full Text] [Related]

  • 19. Combined weekly carboplatin and paclitaxel as primary treatment of advanced epithelial ovarian carcinoma.
    Safra T, Menczer J, Bernstein RM, Shpigel S, Matcejevsky D, Inbar MJ, Golan A, Grisaru D, Levy T.
    Gynecol Oncol; 2009 Aug 25; 114(2):215-8. PubMed ID: 19446318
    [Abstract] [Full Text] [Related]

  • 20. Chemotherapy consisting of cisplatin, doxorubicin and cyclophosphamide as an adjunct to surgery in stage Ic-II epithelial ovarian carcinoma. Gynecologic Oncology Group of the Comprehensive Cancer Center Limburg.
    De Pree N, Wils J.
    Anticancer Res; 1989 Aug 25; 9(6):1873-5. PubMed ID: 2697191
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.